Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Clinical trial NCT04500847 · RECRUITING

Trial details

NCT number: NCT04500847
Sponsor: Butler Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease, Early Onset Mild Cognitive Impairment Moderate Dementia

Start date: 2021-12-17
Primary completion: 2026-03-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.